MRI with Gadolinium-Based Nanoparticles - Nanotechnology for Biomedical Imaging and Diagnostics - page 248

[86] Rudovsky J, Hermann p, Botta M, Aime s, Lukes I. dendrimeric Gd(iii) complex of a
monophosphinated dOTA analogue: optimizing relaxivity by reducing internal motion.
Chem Commun (Camb) 2005; 18 :2390-2392.
[87] Fulton dA, O'Halloran M, parker d, senanayake K, Botta M, Aime s. efficient relaxivity
enhancement in dendritic gadolinium complexes: effective motional coupling in medium
molecular weight conjugates. Chem Commun (Camb) 2005; 4 :474-476.
[88] nwe K, Xu H, Regino CAs, Bernardo M, Ileva L, Riffle L, Wong KJ, Brechbiel
MW. A new approach in the preparation of dendrimer-based bifunctional diethylene-
triaminepentaacetic acid mr contrast agent derivatives. Bioconjug Chem 2009; 20 :
1412-1418.
[89] sato n, Kobayashi H, Hiraga A, saga T, Togashi K, Konishi J, Brechbiel MW.
pharmacokinetics and enhancement patterns of macromolecular MR contrast agents
with various sizes of polyamidoamine dendrimer cores. Magn Reson Med 2001; 46 :
1169-1173.
[90] Yordanov AT, Kobayashi H, english sJ, Reijnders K, Milenic d, Krishna MC, Mitchell
JB, Brechbiel MW. Gadolinium-labeled dendrimers as biometric nanoprobes to detect
vascular permeability. J Mater Chem 2003; 13 :1523-1525.
[91] Kobayashi H, Kawamoto s, star RA, Waldmann TA, Tagaya Y, Brechbiel MW. Micro-
magnetic resonance lymphangiography in mice using a novel dendrimer-based magnetic
resonance imaging contrast agent. Cancer Res 2003; 63 :271-276.
[92] sena LM, Fishman sJ, Jenkins KJ, Xu H, Brechbiel MW, Regino CAs, Kosaka n,
Bernardo M, Choyke pL, Kobayashi H. Magnetic resonance lymphangiography with a
nano-sized gadolinium-labeled dendrimer in small and large animal models. nanomedicine
2010; 5 :1183-1191.
[93] Langereis s, de Lussanet QG, van Genderen MHp, Meijer eW, Beets-Tan RGH, Griffioen
AW, van engelshoven JMA, Backes WH. evaluation of Gd(III)dTpA-terminated
poly(propylene imine) dendrimers as contrast agents for MR imaging. nMR Biomed
2006; 19 :133-141.
[94] Kobayashi H, saga T, Kawamoto s, sato n, Hiraga A, Ishimori T, Konishi J, Togashi K,
Brechbiel MW. dynamic micro-magnetic resonance imaging of liver micrometastasis in
mice with a novel liver macromolecular magnetic resonance contrast agent dAB-Am64-
(1B4M-Gd)64. Cancer Res 2001; 61 :4966-4970.
[95] Kobayashi H, sato n, Kawamoto s, saga T, Hiraga A, Haque TL, Ishimori T, Konishi J,
Togashi K, Brechbiel MW. Comparison of the macromolecular MR contrast agents with
ethylenediamine-core versus ammonia-core generation-6 polyamidoamine dendrimer.
Bioconjug Chem 2000; 12 :100-107.
[96] Kobayashi H, Kawamoto s, saga T, sato n, Hiraga A, Ishimori T, Konishi J, Togashi K,
Brechbiel MW. positive effects of polyethylene glycol conjugation to generation-4 poly-
amidoamine dendrimers as macromolecular MR contrast agents. Magn Reson Med
2001; 46 :781-788.
[97] Kojima C, Turkbey B, Ogawa M, Bernardo M, Regino CAs, Bryant LH, Choyke pL,
Kono K, Kobayashi H. dendrimer-based MRI contrast agents: the effects of peGylation
on relaxivity and pharmacokinetics. nanomedicine 2011; 7 :1001-1008.
[98] Kobayashi H, sato n, Kawamoto s, saga T, Hiraga A, Ishimori T, Konishi J, Togashi K,
Brechbiel MW. novel intravascular macromolecular MRI contrast agent with genera-
tion-4 polyamidoamine dendrimer core: accelerated renal excretion with coinjection of
lysine. Magn Reson Med 2001; 46 :457-464.